rethinkTHC Search
Menu
Study breakdown

Marijuana use was not associated with bladder cancer recurrence in a large prospective study

Prospective CohortStrong evidence
The takeaway

Among 1,472 bladder cancer patients, marijuana use (24.7%) was not associated with cancer recurrence or progression, while tobacco smoking duration and pack-years significantly increased recurrence risk.

Bladder cancer patients who use marijuana, urologists, and cancer survivorship researchers.

Marijuana: no recurrence link. Tobacco 40+ years: 2.4x recurrence risk.

What the researchers found

Longer cigarette smoking duration and more pack-years were associated with higher recurrence risk in a dose-dependent manner (40+ years: HR 2.36; 40+ pack-years: HR 1.97). No associations were found for marijuana, e-cigarettes, pipes, or cigars with bladder cancer recurrence or progression.

Why it matters

With nearly a quarter of bladder cancer patients reporting marijuana use, the absence of a recurrence association is reassuring for patients and clinicians, especially in contrast to the strong tobacco-recurrence link.

The numbers in context

1,472 patients. 363 (24.7%) used marijuana. 59.4% former smokers. 7.5% current smokers. Marijuana: no association with recurrence or progression. Tobacco 40+ years: HR 2.36 (95% CI 1.43-3.91). 40+ pack-years: HR 1.97 (95% CI 1.32-2.95).

How the study worked

Prospective Be-Well Study of 1,472 patients with non-muscle-invasive bladder cancer (NMIBC) diagnosed 2015-2019 in Kaiser Permanente California. Baseline interviews on tobacco, e-cigarette, and marijuana use. Cox regression estimated hazard ratios for recurrence and progression.

What this study cannot tell us

Self-reported substance use at a single time point. Marijuana use details (frequency, amount, duration) not fully captured. Relatively short follow-up (26.4 months). NMIBC-specific findings may not apply to other cancers.

How to read the evidence

Large prospective cohort in an integrated healthcare system with clinical outcomes, published in JAMA Network Open.

When this study was published

Published in 2022, patients diagnosed 2015-2019.

The bigger picture

This adds to the growing evidence that marijuana and tobacco have distinctly different cancer risk profiles, consistent with reviews suggesting marijuana does not appear to cause lung cancer either.

Questions still open

  • Would longer follow-up reveal marijuana associations? Does the route of marijuana administration (smoking vs. edibles) matter for cancer outcomes?

Common questions

Does marijuana affect bladder cancer outcomes?
In this study of 1,472 bladder cancer patients, marijuana use (reported by 25%) was not associated with cancer recurrence or progression, unlike tobacco smoking which significantly increased risk.
Is marijuana safer than tobacco for cancer patients?
This study found no cancer recurrence association with marijuana, e-cigarettes, pipes, or cigars, while tobacco cigarette smoking duration and pack-years strongly predicted bladder cancer recurrence in a dose-dependent pattern.

Read the original research

Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study.

JAMA network open, 5(11), e2244430

Citation

Kwan, Marilyn L; Haque, Reina; Young-Wolff, Kelly C; Lee, Valerie S; Roh, Janise M; Ergas, Isaac J; Wang, Zinian; Cannavale, Kimberly L; Ambrosone, Christine B; Loo, Ronald K; Aaronson, David S; Quesenberry, Charles P; Kushi, Lawrence H; Tang, Li. (2022). Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study.. JAMA network open, 5(11), e2244430. https://doi.org/10.1001/jamanetworkopen.2022.44430

Explore the wider topic